The shot one cuts the hospital RSV Baby by 72 % – and shields for several months

The researchers found the respiratory virus vaccine (RSV), which was presented throughout the United Kingdom in the late summer of 2024, to a 72 percent decrease in children in the hospital with the virus if the mothers are vaccinated.

The results are the first to show the effectiveness of the real world of vaccine in pregnant women in the UK.

Experts say that absorption of lead among pregnant women can help reduce the number of sick children every winter, which reduces hospital pressure.

RSV is a common virus that causes coughing and colds, but it can lead to a severe lung infection called bronchitis, which can be dangerous in children, with some acceptance of intensive care. The virus is the main infectious cause of hospital treatment for children in the UK and the world.

Receiving the vaccine during pregnancy helps protect the mother and child. Antibodies – proteins that help prevent the virus that causes a severe infection – produced by the mother in response to the vaccine to the fetus, provides protection from the severe RSV protection for the first six months after birth.

The research team, under the leadership of Edinburgh and Leicester universities, employed 537 children throughout England and Scotland who were admitted to the hospital with severe respiratory diseases in the winter of 2024-2025, the first season of the implementation of vaccines. 391 children are a positive test for RSV.

The mothers of children who did not have RSV were twice more likely to receive the prenatal vaccine from the mothers of the positive children RSV – 41 percent compared to 19 percent.

The vaccine received more than 14 days before birth, a higher preventive effect, with a 72 percent decrease in hospital acceptance compared to 58 percent of the infants whose mothers were vaccinated at any time before birth.

Experts recommend vaccination as quickly as possible in 28 weeks of pregnancy to provide the best protection, as this gives more time to the mother to generate and antibodies to a child, but can be able to give birth.

Previous research has found that half of the pregnant mothers in England and Scotland are currently getting the RSV vaccine, despite its great success in preventing a serious illness.

Experts say the results highlight the importance of increasing awareness of the availability and effectiveness of the new vaccine to help protect children.

The study was published in the magazine The child forgets and the health of adolescence. Research cooperation also included the Bristol, Oxford, Queens Belfast, Ucl, Impierial College London and 30 hospitals across England and Scotland.

The study was funded by the Federation of Innovative Medicines Viruses (IMI), the respiratory viruses in Europe (RESCEU), and the National Institute of the National Institute of Health Research (NIHR) in respiratory infections, the Empire College in London.

“With an effective RSV vaccine is available and protects themselves from their pioneers from their pioneers throughout breastfeeding throughout the protein,” said Dr. Thomas Williams, a study leadership from the Institute of Renewal and Reform at Edinburgh University, and a pediatrician at the Royal Hospital for Children and Youth in Edinburgh.

“Our work sheds light on the value of vaccination and in keeping with the principle of preventing the NHS 10 -year prevention plan, and we ask all health care systems to consider how to improve the RSV cleansing of mothers,” said Professor Damian Roland of Leicester Hospitals, Universities and Emergency Consultant for Children.